$655.37
-8.13-1.22%
Last update: Nov 4, 10:23 AM
Medpace Holdings Inc (MEDP) Stock Price, Quote, News & History
MEDPNASDAQ
Medpace says second-quarter earnings and revenue beat estimates, backed by stronger bookings, backlog growth and higher 2026 guidance.
You can purchase shares of Medpace Holdings (NASDAQ:MEDP) through any online brokerage.
Other companies in Medpace Holdings’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Medpace Holdings has a consensus price target of $555.75.
The stock price for Medpace Holdings (NASDAQ: MEDP) is $655.365 last updated November 4, 2026 at 10:23 AM EST.
There are no upcoming dividends for Medpace Holdings.
Medpace Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Medpace Holdings.
Medpace Holdings is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including...
